205 related articles for article (PubMed ID: 23640121)
21. Hormone receptor-positive breast cancer and black race: does sex matter?
Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
[TBL] [Abstract][Full Text] [Related]
23. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of mitotic index and Bcl2 expression in male breast cancer.
Lacle MM; van der Pol C; Witkamp A; van der Wall E; van Diest PJ
PLoS One; 2013; 8(4):e60138. PubMed ID: 23573235
[TBL] [Abstract][Full Text] [Related]
25. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.
Nilsson C; Johansson I; Ahlin C; Thorstenson S; Amini RM; Holmqvist M; Bergkvist L; Hedenfalk I; Fjällskog ML
Acta Oncol; 2013 Jan; 52(1):102-9. PubMed ID: 22928693
[TBL] [Abstract][Full Text] [Related]
26. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
[TBL] [Abstract][Full Text] [Related]
27. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
28. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
[TBL] [Abstract][Full Text] [Related]
29. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
Aggarwal A; Adepoju B; Yacur M; Maron D; Sharma MC
Clin Breast Cancer; 2021 Aug; 21(4):e471-e478. PubMed ID: 33619003
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
Serra C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Merino AM; Baltasar A; Pérez-Vázquez MT; Medrano J
Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
32. Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry.
Lee EG; Jung SY; Lim MC; Lim J; Kang HS; Lee S; Han JH; Jo H; Won YJ; Lee ES
Cancer Res Treat; 2020 Jul; 52(3):739-746. PubMed ID: 32054149
[TBL] [Abstract][Full Text] [Related]
33. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
34. Metaplastic breast cancer: clinicopathological features and its prognosis.
Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
[TBL] [Abstract][Full Text] [Related]
35. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
36. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
[TBL] [Abstract][Full Text] [Related]
38. Matched-pair analysis of patients with female and male breast cancer: a comparative analysis.
Foerster R; Foerster FG; Wulff V; Schubotz B; Baaske D; Wolfgarten M; Kuhn WC; Rudlowski C
BMC Cancer; 2011 Aug; 11():335. PubMed ID: 21816051
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
[TBL] [Abstract][Full Text] [Related]
40. Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
Abd-Elhay FA; Elhusseiny KM; Kamel MG; Low SK; Sang TK; Mehyar GM; Nhat Minh LH; Hashan MR; Huy NT
Clin Breast Cancer; 2018 Dec; 18(6):e1293-e1310. PubMed ID: 30093263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
